Japan
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
32.58%
|
July 31, 2024 | USD 2.76 | -3.94% |
|
Japan |
|
2 |
32.04%
|
March 31, 2024 | USD 15.25 | -1.27% |
|
Japan |
|
3 |
27.67%
|
July 31, 2024 | USD 6.35 | -0.89% |
|
Japan |
|
4 |
25.33%
|
Dec. 31, 2023 | USD 8.94 | -0.23% |
|
Japan |
|
5 |
24.08%
|
Dec. 31, 2023 | USD 9.76 | -1.43% |
|
Japan |
|
6 |
23.99%
|
Sept. 30, 2024 | USD 2.93 | -1.24% |
|
Japan |
|
7 |
23.95%
|
Dec. 31, 2023 | USD 21.58 | 0.31% |
|
Japan |
|
8 |
23.29%
|
Dec. 31, 2023 | USD 4.79 | -1.78% |
|
Japan |
|
9 |
23.03%
|
Dec. 31, 2023 | USD 3.39 | -1.15% |
|
Japan |
|
10 |
22.86%
|
June 30, 2024 | USD 8.27 | -1.43% |
|
Japan |
|
11 |
21.89%
|
Dec. 31, 2023 | USD 5.86 | -2.20% |
|
Japan |
|
12 |
20.02%
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
13 |
16.32%
|
March 31, 2024 | USD 10.75 | -2.71% |
|
Japan |
|
14 |
16.21%
|
March 31, 2024 | USD 10.95 | -0.53% |
|
Japan |
|
15 |
16.16%
|
March 31, 2024 | USD 4.97 | -1.23% |
|
Japan |
|
16 |
16.14%
|
March 31, 2024 | USD 10.39 | -0.80% |
|
Japan |
|
17 |
15.68%
|
Sept. 30, 2024 | USD 3.00 | -0.80% |
|
Japan |
|
18 |
15.36%
|
Dec. 31, 2023 | USD 9.78 | -1.94% |
|
Japan |
|
19 |
14.88%
|
Oct. 31, 2023 | USD 5.47 | -1.74% |
|
Japan |
|
20 |
14.63%
|
Oct. 31, 2024 | USD 76.41 | -0.92% |
|
Japan |
|
21 |
14.56%
|
May 31, 2024 | USD 9.32 | -0.86% |
|
Japan |
|
22 |
14.07%
|
March 31, 2024 | USD 12.31 | 0.15% |
|
Japan |
|
23 |
13.55%
|
June 30, 2024 | USD 20.26 | -6.39% |
|
Japan |
|
24 |
13.49%
|
Sept. 30, 2024 | USD 9.46 | -2.05% |
|
Japan |
|
25 |
13.44%
|
Dec. 31, 2023 | USD 3.77 | -0.24% |
|
Japan |
|
26 |
13.19%
|
June 30, 2024 | USD 12.49 | 0.87% |
|
Japan |
|
27 |
13.12%
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
28 |
12.93%
|
March 31, 2024 | USD 9.19 | -0.31% |
|
Japan |
|
29 |
12.86%
|
March 31, 2024 | USD 9.15 | -1.97% |
|
Japan |
|
30 |
12.70%
|
March 31, 2024 | USD 3.38 | -1.89% |
|
Japan |
|
31 |
12.48%
|
March 31, 2024 | USD 4.81 | -0.59% |
|
Japan |
|
32 |
12.26%
|
March 31, 2024 | USD 2.59 | -0.09% |
|
Japan |
|
33 |
12.01%
|
Aug. 31, 2024 | USD 9.32 | -2.24% |
|
Japan |
|
34 |
11.89%
|
March 31, 2024 | USD 27.56 | -3.63% |
|
Japan |
|
35 |
11.81%
|
March 31, 2024 | USD 11.15 | -1.27% |
|
Japan |
|
36 |
11.74%
|
March 31, 2024 | USD 24.26 | -0.77% |
|
Japan |
|
37 |
11.58%
|
March 31, 2024 | USD 29.12 | 0.44% |
|
Japan |
|
38 |
11.51%
|
March 31, 2024 | USD 27.09 | -1.08% |
|
Japan |
|
39 |
11.49%
|
March 31, 2024 | USD 19.21 | -1.38% |
|
Japan |
|
40 |
11.48%
|
Feb. 29, 2024 | USD 12.40 | -1.00% |
|
Japan |
|
41 |
11.15%
|
March 31, 2024 | USD 8.69 | -1.39% |
|
Japan |
|
42 |
11.13%
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
43 |
11.08%
|
March 31, 2024 | USD 17.95 | -0.66% |
|
Japan |
|
44 |
11.06%
|
March 31, 2024 | USD 43.36 | -1.17% |
|
Japan |
|
45 |
11.02%
|
March 31, 2024 | USD 3.06 | 0.05% |
|
Japan |
|
46 |
10.57%
|
May 31, 2024 | USD 46.78 | -2.70% |
|
Japan |
|
47 |
10.48%
|
May 31, 2024 | USD 21.33 | 0.54% |
|
Japan |
|
48 |
10.45%
|
June 30, 2024 | USD 16.87 | -2.21% |
|
Japan |
|
49 |
10.37%
|
March 31, 2024 | USD 19.43 | -1.89% |
|
Japan |
|
50 |
10.17%
|
March 31, 2024 | USD 14.83 | -0.95% |
|
Japan |
The Healthcare company in Japan with the highest Return on Equity (ROE) is Karadanote Inc. (Tokyo Stock Exchange: 4014.T) at 32.58%.
The Healthcare company in Japan with the lowest Return on Equity (ROE) is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at -364.22%.
The top 10 Healthcare companies in Japan by Return on Equity (ROE) are Karadanote Inc., Olympus Corporation, Pharma Foods International Co., Ltd., Japan Hospice Holdings Inc., Mizuho Medy Co.,Ltd., Kanamic Network Co.,LTD, GNI Group Ltd., Elan Corporation, Medical Data Vision Co., Ltd. and Charm Care Corporation.
The bottom 10 Healthcare companies in Japan by Return on Equity (ROE) are OncoTherapy Science, Inc., Oncolys BioPharma Inc., SanBio Company Limited, Solasia Pharma K.K., Carna Biosciences, Inc., Precision System Science Co., Ltd., Data Horizon Corporation, MEDINET Co., Ltd., NanoCarrier Co., Ltd. and StemRIM.